Bone marrow : 60 Hypercellular bone marrow (60-70%) with extensive involvement by leukemia. Histologic sections demonstrate focal sheets of CD34+, CD117+ immature cells. The blasts identified on histologic sections of the marrow are under-represented on the aspirate, which shows 1% blasts, and the flow cytometry specimen, which demonstrates 3% CD45 dim, CD117+, CD34+, CD13+, CD19-, and CD61-myeloblasts. This immunophenotype is consistent with the patient's previous leukemic blasts. 
Cyto-Pathology Classification

Comments
Although AML1-ETO t(8;21)(q22;q22) is a welldescribed cytogenetic anomaly in AML, the t(6;22)(p21;q11.2) seen in this patient's relapse is much more unusual. Few cases have been previously described (Huret, 2010) , and only as anecdotal reports in CML, pre-B ALL, and CLL. This is the first reported case of t(6;22)(p21;q11.2) in a patient with AML. Notably, FISH studies targeting the BCR locus (22q11.2) did not reveal evidence of rearrangement, indicating that BCR is not involved in this (6;22) translocation. The appearance of the (6;22) translocation in the background of the patient's previous cytogenetic abnormality indicates clonal evolution of this progressing acute myeloid leukemia.
This pattern of clonal evolution is particularly interesting in light of the patient's somewhat aggressive clinical course, unusual in t(8;21) AML.
